Hemoglobin decline in cancer patients receiving chemotherapy without an erythropoiesis-stimulating agent

PURPOSE: The aim of this study was to examine the rate and timing of hemoglobin decline from <10 g/dL to <9 g/dL in cancer patients receiving chemotherapy. METHODS: Pooled data from the placebo arms of six randomized, controlled trials (RCTs) of darbepoetin alfa and data from an aggregated US...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Pirker, Robert, Pirolli, Melissa, Quigley, Jane, Hulnick, Scott, Legg, Jason, Collins, Helen, Vansteenkiste, Johan
Format: Artigo
Sprog:Inglês
Udgivet: Springer-Verlag 2012
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3584249/
https://ncbi.nlm.nih.gov/pubmed/23096072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-012-1617-2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker